1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders
US10336732B2 · kind B2 · utility
7Cited by
4References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 21, 2017 |
| Grant date | Jul 2, 2019 |
| Priority date | — |
| Expiry date | Nov 21, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, Ra, R1, R2, R3, R4, R6, w and n1 are defined and described herein; compositions thereof; and methods of use thereof. These compounds are useful for treating a variety of neurological and psychiatric disorders, such as those described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.